DSIP

DSIP was discovered when the dialysate of blood from sleeping donor rabbits was infused into awake recipients, inducing delta-wave (slow-wave) sleep. The active peptide was subsequently isolated and sequenced as the nonapeptide Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.

Despite decades of research, DSIP's receptor has not been definitively identified, and its exact mechanism of action remains an area of active investigation. It appears to act as a neuromodulator rather than a classical neurotransmitter, with widespread distribution in the brain, pituitary, and peripheral tissues including gut and pancreas.

Key pharmacological effects in research include: normalisation of disrupted sleep architecture, HPA axis modulation (blunting of ACTH and cortisol responses to stress), antioxidant activity, and preliminary neuroprotective effects. Its stress-modulating properties make it as relevant to cognitive performance under stress as to sleep itself.

// HPA AXIS MODULATION

DSIP reliably reduces stress-induced ACTH and cortisol elevation without suppressing basal HPA activity. This "stress buffer" effect — modulating the response to stressors without blunting baseline function — is mechanistically distinct from corticosteroids or anxiolytics and is central to its cognitive relevance.

// NEUROMODULATION ACROSS SYSTEMS

DSIP interacts with serotonergic, dopaminergic, GABAergic, and opioidergic systems. Unlike single-target drugs, its polypharmacology as a neuromodulator may explain its broad effects on sleep, stress, pain, and cognition — though it also makes mechanistic attribution difficult.

// SLEEP ARCHITECTURE NORMALISATION

DSIP promotes delta (slow-wave) sleep — the deepest, most restorative sleep stage — without abolishing REM sleep or causing sedation during waking hours. This circadian-appropriate sleep quality improvement has downstream effects on memory consolidation, HGH secretion, and cognitive recovery.

DSIP has been studied in alcohol withdrawal, chronic pain, and insomnia with promising but inconsistent results — partly due to its extremely short half-life (~30 min) and challenges with stable delivery. Analogues with enhanced stability are an active area of research.

Its HPA-blunting properties make it interesting for cognitive performance contexts — chronic stress and elevated cortisol impair hippocampal neurogenesis and working memory, and DSIP's stress buffering could preserve cognitive function under load.